These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26088530)

  • 1. Predictors of Clinical Progression of Subjective Memory Impairment in Elderly Subjects: Data from the Clinical Research Centers for Dementia of South Korea (CREDOS).
    Hong YJ; Yoon B; Shim YS; Kim SO; Kim HJ; Choi SH; Jeong JH; Yoon SJ; Yang DW; Lee JH
    Dement Geriatr Cogn Disord; 2015; 40(3-4):158-65. PubMed ID: 26088530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.
    Jessen F; Wolfsgruber S; Wiese B; Bickel H; Mösch E; Kaduszkiewicz H; Pentzek M; Riedel-Heller SG; Luck T; Fuchs A; Weyerer S; Werle J; van den Bussche H; Scherer M; Maier W; Wagner M;
    Alzheimers Dement; 2014 Jan; 10(1):76-83. PubMed ID: 23375567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological performance and conversion to Alzheimer's disease in early- compared to late-onset amnestic mild cognitive impairment: CREDOS study.
    Ye BS; Seo SW; Lee Y; Kim SY; Choi SH; Lee YM; Kim DH; Han HJ; Na DL; Kim EJ
    Dement Geriatr Cogn Disord; 2012; 34(3-4):156-66. PubMed ID: 23037957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory impairment, in mild cognitive impairment without significant cerebrovascular disease, predicts progression to Alzheimer's disease.
    Lee YM; Park JM; Lee BD; Moon E; Chung YI; Kang CJ
    Dement Geriatr Cogn Disord; 2012; 33(4):240-4. PubMed ID: 22738930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Conversion or Reversion of Mild Cognitive Impairment in Community versus Hospital Based Studies: GDEMCIS (Gwangju Dementia and Mild Cognitive Impairment Study) and CREDOS (Clinical Research Center for Dementia of South Korea).
    Roh HW; Hong CH; Lee Y; Lee KS; Chang KJ; Kang DR; Lee JD; Choi SH; Kim SY; Na DL; Seo SW; Kim DK; Back JH; Chung YK; Lim KY; Noh JS; Son SJ
    J Alzheimers Dis; 2016 May; 53(2):463-73. PubMed ID: 27163831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of subjective memory impairment in the elderly: association with memory performance.
    Jessen F; Wiese B; Cvetanovska G; Fuchs A; Kaduszkiewicz H; Kölsch H; Luck T; Mösch E; Pentzek M; Riedel-Heller SG; Werle J; Weyerer S; Zimmermann T; Maier W; Bickel H
    Psychol Med; 2007 Dec; 37(12):1753-62. PubMed ID: 17623488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of depression in the insomnia of people with subjective memory impairment, mild cognitive impairment, and dementia in a community sample of elderly individuals in South Korea.
    Kim WH; Kim JH; Kim BS; Chang SM; Lee DW; Cho MJ; Bae JN
    Int Psychogeriatr; 2017 Apr; 29(4):653-661. PubMed ID: 27921991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study.
    Liew TM
    Aust N Z J Psychiatry; 2022 Dec; 56(12):1664-1675. PubMed ID: 35229693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Profiles of Arteriolosclerosis and Alzheimer Disease at Mild Cognitive Impairment and Mild Dementia in a National Neuropathology Cohort.
    Yang D; Masurkar AV
    Alzheimer Dis Assoc Disord; 2021 Jan-Mar 01; 35(1):14-22. PubMed ID: 32925200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment.
    Jessen F; Wiese B; Bachmann C; Eifflaender-Gorfer S; Haller F; Kölsch H; Luck T; Mösch E; van den Bussche H; Wagner M; Wollny A; Zimmermann T; Pentzek M; Riedel-Heller SG; Romberg HP; Weyerer S; Kaduszkiewicz H; Maier W; Bickel H;
    Arch Gen Psychiatry; 2010 Apr; 67(4):414-22. PubMed ID: 20368517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
    J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecological assessment of mild cognitive impairment and Alzheimer disease using the Rivermead Behavioural Memory Test.
    Bolló-Gasol S; Piñol-Ripoll G; Cejudo-Bolivar JC; Llorente-Vizcaino A; Peraita-Adrados H
    Neurologia; 2014; 29(6):339-45. PubMed ID: 24139389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective memory impairment on an adapted Mini-Mental State Examination increases risk of future dementia.
    Olazarán J; Trincado R; Bermejo F; Benito-León J; Díaz J; Vega S
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1173-80. PubMed ID: 15526309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume.
    Striepens N; Scheef L; Wind A; Meiberth D; Popp J; Spottke A; Kölsch H; Wagner M; Jessen F
    Psychol Med; 2011 Sep; 41(9):1997-2006. PubMed ID: 21284913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.